From: MMP-1 serum levels predict coronary atherosclerosis in humans
Characteristics: | n = 260 |
---|---|
Age (yrs) | 63 (54 - 69) |
Men (%) | 66.8 |
Classical CV-Risk Factors (%) | |
Diabetes* | 6.2 |
Hypertension* | 47.3 |
Family history of CAD** | 26.9 |
Smoking** | 15 |
Body Mass Index (kg/m2) | 26.2 (24.2 - 29.3) |
Laboratory profile | |
Total cholesterol (mg/dl) | 209 (181.2 - 239) |
LDL cholesterol (mg/dl) | 125 (96.7 - 151) |
HDL cholesterol (mg/dl) | 52 (44 - 60) |
Triglycerides (mg/dl) | 141 (103 - 197.5) |
C-reactive protein (mg/dl) | 0.23 (0 - 0.53) |
Adiponectin (ug/ml) | 5.05 (3.25 - 7.67) |
MMP-1 (ng/ml) | 3.91 (2.24 - 5.67) |
MMP-9 (ng/ml) | 211.3 (147.1 - 283) |
Medical treatment (%)*** | |
Statin | 37.7 |
Anticoagulation/Antiplatelet | 63.5 |
Betablocker | 64.9 |
ACE-I or ARB | 51.8 |
Diuretics | 30.6 |
CT data | |
Pericardial adipose tissue in volume (ml)§ | 184.1 (128.6 - 255.8) |
Number of coronary artery plaques (total)§§ | 3 (1 - 6) |
Number of calcified plaques (154 patients) | 1 (0 - 3) |
Number of mixed plaques (102 patients) | 0 (0 - 1) |
Number of non-calcified plaques (126 patients) | 0 (0 - 2) |